Diabetes: Oral Insulin

• Orally delivered, chemically unaltered human insulin

• Drug market for Type 2 diabetes estimated to reach $20 billion in 2010*

  • Potential to be first-line therapy

*Source: Natexis Bleichroeder, “Diabetes is set for major innovation”, 9/03

Previous slide

Next slide

Back to first slide

View graphic version